ATE382334T1 - Gelatine-freie schell dispergierende dosisformen - Google Patents

Gelatine-freie schell dispergierende dosisformen

Info

Publication number
ATE382334T1
ATE382334T1 AT00908371T AT00908371T ATE382334T1 AT E382334 T1 ATE382334 T1 AT E382334T1 AT 00908371 T AT00908371 T AT 00908371T AT 00908371 T AT00908371 T AT 00908371T AT E382334 T1 ATE382334 T1 AT E382334T1
Authority
AT
Austria
Prior art keywords
dosage forms
solid dosage
active ingredient
gelatine
dose forms
Prior art date
Application number
AT00908371T
Other languages
English (en)
Inventor
Leon Paul Grother
Owen James Murray
Richard Green
Patrick Kearney
Original Assignee
Scherer Corp R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Corp R P filed Critical Scherer Corp R P
Application granted granted Critical
Publication of ATE382334T1 publication Critical patent/ATE382334T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00908371T 1999-01-27 2000-01-27 Gelatine-freie schell dispergierende dosisformen ATE382334T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9901819.4A GB9901819D0 (en) 1999-01-27 1999-01-27 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE382334T1 true ATE382334T1 (de) 2008-01-15

Family

ID=10846608

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00908371T ATE382334T1 (de) 1999-01-27 2000-01-27 Gelatine-freie schell dispergierende dosisformen

Country Status (25)

Country Link
EP (1) EP1154757B1 (de)
JP (1) JP4863336B2 (de)
KR (1) KR100852015B1 (de)
CN (1) CN1193740C (de)
AT (1) ATE382334T1 (de)
AU (1) AU768121B2 (de)
BG (1) BG65413B1 (de)
CA (1) CA2360647C (de)
CY (1) CY1107384T1 (de)
CZ (1) CZ301249B6 (de)
DE (1) DE60037653T2 (de)
DK (1) DK1154757T3 (de)
ES (1) ES2298129T3 (de)
GB (1) GB9901819D0 (de)
HK (1) HK1037536A1 (de)
HU (1) HU226557B1 (de)
IL (2) IL144412A0 (de)
IS (1) IS2678B (de)
NO (1) NO331253B1 (de)
PL (1) PL197462B1 (de)
PT (1) PT1154757E (de)
RU (1) RU2242968C2 (de)
TR (1) TR200102504T2 (de)
WO (1) WO2000044351A1 (de)
ZA (1) ZA200105930B (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9904049D0 (en) * 1999-02-22 1999-04-14 Quadrant Holdings Cambridge Rapidly-soluble compositions
US7550156B2 (en) * 2001-11-23 2009-06-23 Rohm And Haas Company Optimised pellet formulations
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
WO2003094886A2 (en) * 2002-05-07 2003-11-20 Ferring Bv Desmopressin in an orodispersible dosage form
DE10237459A1 (de) * 2002-08-16 2004-02-26 Beiersdorf Ag Wirkstoffhaltige kosmetische Zubereitung
WO2004047793A1 (en) * 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
UA93479C2 (en) * 2002-11-26 2011-02-25 Альк-Абелло A/C Allergen dosage form
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
WO2004075875A1 (en) 2003-02-28 2004-09-10 Alk-Abello A/S Dosage form having a saccharide matrix
ITRM20030288A1 (it) * 2003-06-10 2004-12-11 Valerio Cioli Somministrazione sublinguale di antinfiammatori non steroidei (fans)
EP2322195A2 (de) 2003-11-10 2011-05-18 Reprise Biopharmaceutics, LLC Pharmazeutische Zusammensetzungen mit niedrigen Dosen von Desmopressin
DE20321887U1 (de) 2003-11-10 2012-01-20 Allergan, Inc. Arzneimittel umfassend niedrige Dosierungen von Desmopressin
PT1530967E (pt) 2003-11-13 2006-09-29 Ferring Bv Embalagem blister e uma forma de dosagem solida que compreende desmopressina.
US20060210590A1 (en) 2005-02-03 2006-09-21 Alk-Abello A/S Minor allergen control to increase safety of immunotherapy
JP2009510136A (ja) 2005-10-04 2009-03-12 アルク−アベッロ エイ／エス 固体ワクチン製剤
CN101548958B (zh) * 2008-04-03 2012-10-17 万特制药(海南)有限公司 一种含有盐酸特比萘芬的分散片
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
ES2710454T3 (es) 2008-05-21 2019-04-25 Ferring Bv Desmopresina bucodispersable para aumentar el periodo inicial de sueño ininterrumpido por nocturia
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
DE102008051579A1 (de) * 2008-10-14 2010-04-15 Rhodia Acetow Gmbh Biologisch abbaubarer Kunststoff und Verwendung desselben
AU2010249615B2 (en) 2009-05-19 2013-07-18 Celgene Corporation Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione
PL3679941T3 (pl) 2009-06-18 2023-04-17 Serenity Pharmaceuticals Llc Bezpieczne podawanie desmopresyny
EP3332772A1 (de) * 2009-10-30 2018-06-13 IX Biopharma Ltd Schnell lösliche feste darreichungsform
US10548839B2 (en) 2010-03-16 2020-02-04 Wei Tian Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form
WO2011121515A1 (en) * 2010-03-29 2011-10-06 Firmenich Sa Spray-dried crystalline active ingredient
NZ619857A (en) 2010-03-29 2015-05-29 Ferring Bv A fast dissolving pharmaceutical composition
JO3112B1 (ar) 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
KR101751964B1 (ko) * 2010-10-08 2017-06-28 알.피.쉐러 테크놀러지즈 엘엘씨 전분을 이용한 경구 백신 급속 용해성 투여 형태
KR20140061438A (ko) 2011-09-16 2014-05-21 훼링 비.브이. 속용성 약학 조성물
RU2497505C1 (ru) * 2012-11-07 2013-11-10 Максим Эдуардович Запольский Новая лекарственная композиция для лечения болевого синдрома при спазме гладкой мускулатуры
RU2503447C1 (ru) * 2012-11-20 2014-01-10 Максим Эдуардович Запольский Лекарственное средство в форме ородисперсной таблетки и способ получения лекарственного средства
EP2952200A1 (de) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen zur vorbeugenden Behandlung von Allergien
CN106259891A (zh) * 2015-05-28 2017-01-04 上海旺旺食品集团有限公司 一种益生菌口含片及其制备方法
RU2674765C2 (ru) * 2016-10-03 2018-12-13 Михаил Лукич Ткаченко Антигрибковая композиция эвтектического типа (варианты)
KR20240031326A (ko) 2016-12-31 2024-03-07 바이오엑셀 테라퓨틱스 인코포레이티드 불안의 치료를 위한 설하 덱스메데토미딘의 용도
MX2020014000A (es) 2018-06-27 2021-06-15 Bioxcel Therapeutics Inc Formulaciones en lámina que contienen dexmedetomidina y métodos para producirlas.
MX2022000709A (es) 2019-07-19 2022-05-19 Bioxcel Therapeutics Inc Regimenes de tratamiento con dexmedetomidina no sedante.
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
NL8304133A (nl) * 1983-12-01 1985-07-01 Unilever Nv Water-in-olie emulsies die gehydrateerde zetmeelkorrels bevatten.
DE4018247A1 (de) * 1990-06-07 1991-12-12 Lohmann Therapie Syst Lts Herstellungsverfahren fuer schnellzerfallende folienfoermige darreichungsformen
ATE208615T1 (de) * 1993-07-09 2001-11-15 Scherer Corp R P Verfahren zur herstellung von gefriergetrockneten arzneistoffdosierungsformen
GB9401892D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
CN1222317C (zh) * 1996-07-12 2005-10-12 第一制药株式会社 可迅速崩解的压模物质及其生产方法
JP4292588B2 (ja) * 1997-01-31 2009-07-08 日産化学工業株式会社 ピリダジノン化合物類の経口製剤

Also Published As

Publication number Publication date
PL197462B1 (pl) 2008-04-30
CN1193740C (zh) 2005-03-23
TR200102504T2 (tr) 2002-08-21
IS2678B (is) 2010-09-15
RU2242968C2 (ru) 2004-12-27
BG105739A (en) 2002-06-28
JP2003529535A (ja) 2003-10-07
CZ20012700A3 (cs) 2002-08-14
DE60037653T2 (de) 2008-10-30
KR20010111565A (ko) 2001-12-19
DE60037653D1 (de) 2008-02-14
WO2000044351A1 (en) 2000-08-03
IL144412A0 (en) 2002-12-01
ES2298129T3 (es) 2008-05-16
CA2360647A1 (en) 2000-08-03
BG65413B1 (bg) 2008-07-31
PT1154757E (pt) 2008-03-17
HUP0105107A2 (en) 2002-06-29
IS6023A (is) 2001-07-25
HK1037536A1 (en) 2002-02-15
IL144412A (en) 2006-06-11
CN1337876A (zh) 2002-02-27
EP1154757A1 (de) 2001-11-21
ZA200105930B (en) 2002-10-18
HUP0105107A3 (en) 2006-07-28
NO20013679L (no) 2001-09-19
NO20013679D0 (no) 2001-07-26
AU2972900A (en) 2000-08-18
EP1154757B1 (de) 2008-01-02
CZ301249B6 (cs) 2009-12-23
CY1107384T1 (el) 2012-01-25
CA2360647C (en) 2005-08-02
DK1154757T3 (da) 2008-05-13
EP1154757A4 (de) 2004-01-21
JP4863336B2 (ja) 2012-01-25
NO331253B1 (no) 2011-11-07
HU226557B1 (en) 2009-03-30
AU768121B2 (en) 2003-12-04
GB9901819D0 (en) 1999-03-17
KR100852015B1 (ko) 2008-08-12

Similar Documents

Publication Publication Date Title
ATE382334T1 (de) Gelatine-freie schell dispergierende dosisformen
HUP0000141A2 (hu) Eljárás legfeljebb 90 tömeg% gyógyhatású anyagot tartalmazó pelletek előállítására
BE901994A (fr) Comprimes de principes actifs pharmaceutiques a delitement rapide, stables au stockage.
EA200001125A1 (ru) Гелеобразные фармацевтические композиции
RU2004111596A (ru) Офтальмические композиции в форме депо для периокулярного или субконъюнктивального введения
ATE234634T1 (de) Feste pharmazeutische formulierungen enthaltend eine physische mischung aus sulphoalkylethercyclodextrin und einem therapeutischen wirkstoff
FI962111A (fi) Mikrokapseloidut 3-piperidinyyli-substituoidut 1,2-bentsisoksatsolit ja 1,2-bentsisotiatsolit
NO980669D0 (no) Orale raskt-opplöselige blandinger for dopaminagonister
ATE356614T1 (de) Veränderung der wirkstoffladung in multivesikulären liposomen
FI842528A (fi) Fasta farmaceutiska preparat fraon vilka frigoeringen av det aktiva aemnet sker laongsamt via reglerad yterosion.
EA200700055A1 (ru) Препаративные формы пероральных лекарственных форм мемантина с немедленным высвобождением
BR9908371A (pt) Formulação preservante lìquida de amplo espectro, método para sua preparação, solução de iodopropargila estabilizada e processo para eliminar ou retardar o crescimento de micróbios
HUP0203121A2 (hu) Szubsztituált benzimidazolokat tartalmazó gyógyszerkészítmény és alkalmazása
ATE444739T1 (de) Polymerzusammensetzung sowie diese enthaltende darreichungsformen
TR199900584T2 (xx) Amino asit esteri i�eren azol mantar �nleyiciler.
ATE359248T1 (de) Rauch erzeugende zusammensetzung
DK1216043T3 (da) Formulering med forsinket frigivelse indeholdende alfa-liponsyre-(derivater)
FR2719771B1 (fr) Compositions pharmaceutiques contenant du gemfibrozil.
MY101266A (en) Pharmaceutical formulations
AR036323A1 (es) Formas de dosis de rapida dispersion, libres de gelatina
MXPA05012655A (es) Isomeros puros d-(17a)-13 -etil-17-hidroxi -18, 19-dinorpregn- 4-eno-20-ino -3-ona-3e -y ??3z- oxima, asi como el proceso para la sintesis de la mezcla de isomeros y los isomeros puros.
RS52818B (sr) Farmaceutska formulacija sa kontrolisanim otpuštanjem koja sadrži natrijum alginat i natrijum kalcijum alginat
EA200100794A1 (ru) Фармацевтическая композиция, ее применение и способ получения

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1154757

Country of ref document: EP

EEFA Change of the company name